Navigation Links
Oral Transmucosal Drug Delivery. Products, Players, Markets & Forecasts
Date:3/19/2013

DUBLIN, Ireland, March 19, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Oral Transmucosal Drug Delivery. Products, Players, Markets & Forecasts" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2015 as buccal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.

Highlights:

- Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market

- Analyzes oral transmucosal drug products and pipeline product candidates

- Provides assessments of key oral transmucosal drug therapeutic categories

- Provides market data and forecasts to 2016

- Profiles market participants, their product development activities and strategies

Key Topics Covered:

- Executive Summary
- Drug Delivery Market Dynamics
- Competing Transmucosal Delivery Technologies
- Commercial Transmucosal Formulation Platforms
- Oral Transmucosal Drug Technology Factors
- FDA-Approved Oral Transmucosal Products
- Important Pipeline Product Candidates
- Market Assessments & Forecasts
- Market Factors
- Market Participant Profiles

For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/ltg5xz/oral_transmucosal

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Drug Delivery



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
2. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
3. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
4. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
5. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
6. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
7. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
8. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
9. Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities
10. China Biologic Products, Inc. Adopts Stockholder Rights Plan
11. Wright Therapy Products, Inc. Closes $3 million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... fiscal year ended December 31, 2016. ... This news release should ... and management discussion and analysis for the years ended December ... and are available at www.sedar.com and on the ...
(Date:2/22/2017)... Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) ... 2016 investor conference call and webcast at 8:30 a.m., Eastern ... will cover an update on Merrimack,s recent progress as well ... financial results. A press release detailing the information to be ... Wednesday, March 1. Investors and the general public are invited ...
(Date:2/22/2017)... 2017 Summary Provides understanding and ... and agreements entered into by the worlds leading healthcare ... Description The Global Non-Small Cell Lung Cancer Partnering ... access to partnering deals and agreements entered into by ... in partnering deals - Top deals by value ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 22, 2017 , ... ANGLESTRONG , the new recovery management app with ... App Store and Google Play . Florida-based Sober Network, Inc., the ... industry, partnered with Angle to build ANGLESTRONG. The new recovery management app is a ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting a ... derive a heart-protective benefit from eating soy foods, while others do not, a University ... are able to produce equol—a substance made by some types of “good” gut bacteria ...
(Date:2/22/2017)... ... 2017 , ... Super-Sod will attend the Athens Home Show with a brand ... shift from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit space ... manager Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm in ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a home ... University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, March ... Aging is a tremendous resource in our community. We are thrilled to participate in ...
(Date:2/22/2017)... ... February 22, 2017 , ... Apptricity® Corporation, a leading global ... management, today announced that Keppel Corporation has selected Apptricity Travel and Expense Management ... “We are excited to announce the partnership between Keppel and Apptricity for our ...
Breaking Medicine News(10 mins):